Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Choosing the right accounts and locations for index funds can reduce taxable distributions and improve net returns over time.
15,987 articlesA new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Bitcoin trades near $63,000 as pardon discussions around Sam Bankman-Fried surface in crypto news. A $32 million hack...
Solana shows a tentative rebound from the $60 support level, but a long road remains. Traders weigh oversold readings...
June 11 brought a surprising twist: Coupang’s privacy fine landed below feared levels, sending the stock higher and l...
As Congress stalls on federal AI regulation, states are advancing targeted laws on chatbot interactions, employer use...
In 2026, Marvell Technology has become a focal point for investors. This article breaks down the drivers behind the r...
After years of policy shifts and supply hiccups, a clearer EV roadmap is starting to emerge. This analysis explains w...
Nuclear power is staging a comeback, and it could reshape how you invest in utilities. This guide breaks down why the...
A brutal four-session selloff in Korea’s chip sector erased roughly $900 billion in market value, even as analysts in...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
A single metric helps explain the uneasy mood among Americans: the declining share of income going to workers as prof...
In 2026, investors face a choice between a diversified mid-tier producer and the world's largest gold miner. This gui...